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SUSTAINED ADRENERGIC SIGNALING PROMOTES CERVICAL CANCER 
TUMOR PROGRESSION 
Nouara C. Sadaoui, B.A. 
Advisory Professor: Anil K. Sood, M.D. 
Background: Chronic stress and sustained adrenergic signaling are known to 
promote tumor progression. The underlying mechanisms behind this process are 
not well understood. We examined the effects of sustained adrenergic signaling 
on cervical cancer progression through increased expression of HPV oncogenes, 
E6 and E7.  
Materials and Methods: ADRβ expression levels were examined in patient-
derived cervical cancer samples. We used an orthotopic model of cervical cancer 
to investigate the effects of restraint stress on tumor growth and metastasis. We 
evaluated the in vivo effects of a β-blocker, propranolol, and HPV E6/E7 siRNA. 
In vitro, ADRβ positive cervical cancer cell were treated with norepinephrine (NE) 
or isoproterenol (ISO) to examine intracellular responses. Invasion and anoikis 
assays were performed to elucidate the biological effect of NE. Furthermore, the 
significance of secreted HPV was examined.  
Results: Among tumor samples evaluated from cervical cancer patients, 61% 
had increased ADRβ2 expression, which correlates with decreased overall 
survival (p=0.038). In an orthotopic model of cervical cancer, chronic stress led to 
increased tumor weight and nodules. This effect was abrogated with propranolol. 
Further, treatment with HPV E6/E7 siRNA in the restraint stress model 
decreased tumor growth and metastases. In vitro, HPV E6/E7 mRNA was 
vi	  	  
elevated in cell lysates and corresponding supernatant after treatment with NE or 
ISO. NE exposure resulted in increased invasion and migration of SiHa cells, 
while E6/E7 siRNA abrogated these effects. After NE exposure, ME-180 cells 
showed a 45% reduction in anoikis compared to controls. Fibroblasts cultured 
with supernatant from SiHa cells had increased migration and elevated mRNA of 
pro-inflammatory genes CXCL2 and IL-8. Further, the fibroblasts took up cervical 
cancer cell derived exosomes that contain HPV E7. The conditioned fibroblasts 
demonstrated the ability to increase cervical cancer cell invasion when co-
cultured.  
Conclusion: This study shows increased adrenergic signaling promotes cervical 
cancer growth and progression. Disruption of this pathway with β-blockers could 
provide a novel complement to current therapies. In addition, we show HPV 
oncogenes E6 and E7 can be influenced by catecholamines. We also show 
exosomes as a potential mean of communication between cervical cancer cells 
and fibroblasts in vitro. The functional implications of this study need to be 
explored further.  
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Background and Introduction 
Cervical cancer 
There are an estimated 12,000 new cases of cervical cancer in the US 
each year and about a third of the women affected die because of the 
disease. Globally, the disease causes around a 250,000 deaths a year [1]. 
The primary cause of cervical cancer is human papillomavirus (HPV); 
additional contributors include cigarette smoking, multiple sex partners, and 
immunosuppression [2]. The death rate from cervical cancer in developed 
countries has declined about 70% in the past 50 years because of increased 
use of the Papanicolaou (Pap) test [3]. The Pap test is performed by 
collecting cells from the outer opening of the cervix, which are then analyzed 
for abnormalities in aims of detecting early pre-cancerous lesions and 
cancer.   
In early stages of the disease, conization or hysterectomy is used to 
remove cancerous lesions. Radiation and chemotherapy may be used for 
disease with regionalized spread [4]. Advanced cervical cancer can spread 
into the vagina and uterus, growing onto the muscular wall of the pelvis, and 
even can block one or both ureters, bladder, or rectum. The cancer can also 
metastasize to distant organs such as the liver and lungs. Larger early stage 
tumors typically require radical hysterectomy, including removal of local 
lymph nodes [5]. Palliative care is important in order to improve quality of life 
and relieve symptoms from treatment. 
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Human papillomavirus (HPV)  
The primary cause of cervical cancer is the HPV. There are over 100 
different strains of HPV; among these there are low risk types (6 and 11) 
which are most commonly associated with warts, and the high-risk types 
(HPV16, 18, 31, 33,45, 52, and 58) which are associated with cancer [6] [7]. 
High risk-HPV (HR-HPV) types 16 and 18 account for 70% of the HPV 
positive cervical cancer tumors [8].  The virus first infects the basal layer of 
the epithelium, typically entry is through an abrasion that exposes the basal 
cells [7]. The capability of the virus to directly infect stromal cells has not 
been previously described nor accepted in the virology field, HPV only infects 
basal cells of the skin and mucosa [9]. During the establishment of infection, 
the virus associates with heparan sulphate proteoglycans (HSPG) on the cell 
surface prior to being internalized [10]. The cell and virus replicate together 
in the proliferative layers of the epithelium. In the top layers of the epithelium, 
the virus is fully packaged and expression of all the viral proteins is high. The 
encapsidated virus can exit the cell as infectious virus particles at this point. 
Conversely, the virus can remain in a latent phase, in which viral replication 
has ceased [11]. In latency, viral gene expression is minimal and the virus is 
maintained episomally or integrated in host DNA. Persistent infection with 
HPV and additional aberrations in the cell ultimately lead to the tumor growth 
[12].  
The virus is a small double stranded DNA virus (Figure 2). The genome 
has an upper regulatory region (URR), 6 early open reading frames (ORF) 
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(E1, E2, E4, E5, E6, E7), and 2 late ORFs (L1 and L2) [13]. After the host cell 
is infected early genes E1 and E2 are expressed which play roles in 
transcription and replication of the virus [14]. The E2 protein binds specific 
regions in the URR to negatively regulate the E6/E7 promoter. E6 and E7, the 
oncogenes of the virus, are transcribed bi-cistronically [15].The URR also 
contains other transcription factor binding sites that have been shown to 
modulate the promoter function as well, such as AP1, Oct-1, SP1, and 
glucocorticoid response elements [16]. The two late genes L1 and L2 encode 
the capsid protein coat of the virus [17]. 
 
 
Figure 1. Illustration of HPV in the cell. The HR-HPV episome contains all 
8 genes and an URR, typically spanning 8,000bp. The most common 
integrated form of HPV contains an undisrupted URR, E6 and E7. Loss of E2 
inhibitory effects plus stable expression of the oncogenes results in cellular 
immortality, increased proliferation, and genomic instability[12].  
 
4	  	  
 
HPV oncogenes: E6 and E7 
The E6 protein has many known interactions and functions in the cell. The 
most canonical oncogenic function is the ability to inactivate p53-dependent 
growth arrest and apoptosis [18]. Additional functions include the degradation 
of pro-apoptotic proteins BAX and BAK [19], and to promote immortalization 
E6 has a known role in up regulating the transcription of hTERT [20].   
E7 proteins associate with the retinoblastoma protein to induce hyper 
proliferation. This interaction allows E2F6 mediated cell cycle progression 
through the S-phase, which for viral genome replication is favorable [21]. E7 
has also been shown to deregulate the cell cycle by directly interacting with 
p21 and p27 [22].   
 
Stress and cancer 
Studies have shown a strong relationship between psychosocial factors, 
including depression, low social support, and hopelessness, and cancer 
progression [23]. Cervical cancer patients typically present with greater 
disruptions in quality of life (QOL) than in other cancers; factors that 
contribute to their psychosocial distress include poor coping skills, 
depression, anxiety, social isolation, and drug use [23]. Unfortunately, cervical 
cancer patients without social and clinical support service and the lack of 
access to care, often face a delay in diagnosis and have advanced disease at 
presentation [24]. For cervical cancer specifically, in one study patients were 
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given a stressful life events (SLE) assessment as a measure of psychosocial 
distress and those with higher scores were associated with higher risk for 
squamous intraepithelial lesions (SIL) [25]. In another study, women with 
negative coping styles were also more likely to have SIL when compared to 
those with positive coping styles [26]. High levels of pessimism, despair, 
anxiety, and uncontrollable stressors are all associated with higher risk for SIL 
[27]. Studies to date are correlative and future investigation of the 
mechanisms behind this relationship need to be explored.  
 
Figure 2. The stress response. In response to a stimulus both the 
hypothalamic-pituitary-adrenal axis (HPA) and sympathetic nervous system 
(SNS) are activated to adapt physiologically to a threat. Through the HPA axis 
the hypothalamus secretes corticotrophin releasing factor (CRF) and arginine 
vasopressin (AVP), which activate the pituitary to produce hormones such as 
adrenocorticotropic hormone (ACTH). Circulating ACTH stimulates production 
of glucocorticoids. Additionally, when sympathetic nerves of the SNS are 
activated, they can also result in the release of epinephrine and 
norepinephrine. 
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Activation of the SNS or HPA prepares an individual to survive a threat 
and the physiological stress responses are considered adaptive (Figure 2) 
[28]. The acute stress response is commonly known as the “fight or flight” 
response and has a clear onset and offset with transient changes in 
hormones. However, under chronic stress the physiological systems are 
negatively affected by persistent elevation of stress hormone levels [29]. 
Studies of behavioral stress in animals have provided reliable models for 
dissecting stress effects on tumor progression [30]. Restraint stress, swim 
stress, social confrontation or isolation are models commonly used for 
inducing experimental stress [30]. These models accurately mimic 
physiological stress pathway activation which disrupts homeostasis as seen 
in patients [31]. Previous studies in vivo suggest chronic stress plays a role in 
tumor growth and metastasis. In an orthotopic murine model of breast cancer, 
chronic stress increased lung metastases significantly [32]. In another study, 
restraint stress led to increased production of vascular endothelial growth 
factor (VEGF), and enhanced angiogenesis and tumor burden in an 
orthotopic murine model of ovarian cancer [33]. In vitro effects of stress 
hormones parallel the results seen in animal models. Catecholamine 
exposure led to increased expression of metalloproteinase (MMP) 2 and 9, 
which increased ovarian cancer cell invasion compared to control [34]. 
Furthermore, ovarian cancer cells exposed to NE induced FAK-mediated 
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resistance to anoikis [35].  Adrenergic stimulation also has been shown to 
play a role in suppressing NK cell activity [36].  
β-adrenergic signaling is the primary mediator of the SNS induced 
responses involved in the promotion of cancer [37]. Because this signaling 
pathway has shown to be critical in tumor progression, β antagonist/blockers 
provide an appealing adjuvant therapy strategy for abrogating the impact of 
stress.  Studies done in patients with prostate, lung, ovarian, and breast 
cancers have shown higher survival and lower recurrence and metastasis 
rates when taking a β-blocker [38]. Current studies have not addressed β-
blockers use in cervical cancer patients however; many clinical based 
assessments have supported the use of β-blockers in patient interventions 
[39].  
Although the effects of stress and cancer are established, the role of 
stress in viral oncology is not well studied [40]. HPA or SNS can directly 
affect; viral replication, and activation of viral oncogenes, or indirectly bio-
behavioral factors can cause evasion of immune response [41]. 
Neuroendocrine function has been shown to modulate tumor associated 
viruses such as; Hepatitis B and C virus, Kaposi’s sarcoma-associated 
herpes virus (KSHV), Human immunodeficiency virus 1 (HIV1), and Epstein–
Barr virus (EBV). Under chronic stress reactivation and increased expression 
of EBV and Hepatitis B and C viruses has been reported [42] [43]. β-
adrenergic signaling induces a viral transcription factor in KSHV via a 
cAMP/PKA signaling pathway directly promoting lytic replication of the virus 
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[44]. Additionally, in cells infected with HIV1, replication was accelerated in 
response to norepinephrine through a PKA-dependent mechanism [45]. To 
our knowledge no relationship between catecholamine’s and HPV has been 
shown. 
 
Fibroblasts in the tumor microenvironment  
Fibroblasts are a non-epithelial cell type in connective tissue primarily 
responsible for depositing extracellular matrix. Fibroblasts are often referred 
to as a scaffolding cell type, which have a well-studied role in wound healing 
[46], regulation of epithelial cell differentiation [47], and regulation of 
inflammation [48].  An activated fibroblast is referred to as a myofibroblast 
and this is associated with the type found in wound healing and more recently 
tumors [49]. The fibroblast associated with cancer cells and the tumor stroma 
are known as carcinoma-associated fibroblasts (CAFs) [50]. Studies of 
fibroblasts in the tumor microenvironment compared to normal fibroblasts 
have shown increases in migration, increases in pro-inflammatory genes, and 
increased growth factor secretion [51]. CAFs can be distinguished from 
normal fibroblast by their expression of fibroblast activating protein (FAP) [52] 
and increases in alpha-smooth muscle actin (α-SMA) protein [53]. How CAFs 
might contribute to the promotion of cancer is currently a very broad and 
popular topic of interest.  
 
Exosomes 
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For intercellular communication, cells can release vesicles known as 
exosomes. Exosomes origin is from endosomes and their size ranges from 
30-120 nm [54].  The most common pathways used for exosomal release are 
dependent upon SMPD2, Rab family proteins (Rab11,27,35), and ESCRT 
machinery proteins[55]. These vesicles can transfer biological information, 
such as membrane receptors, mRNAs, RNA, DNA, or proteins, between cells 
[56]. Exosomes content and proposed function can be different depending on 
the type of cell that release them (epithelial cells, macrophages, platelets) 
[57].  Extracellular vesicles content and specifically how to target these 
pathways in cancer are being studied extensively [55, 58].  
Recent studies have shown tumor-associated viruses (HSV, HIV, and 
EBV) have release and uptake mechanisms similar to exosomes [59]. 
Further, virus containing cells can infect surrounding cells via microvesicles 
[60] [61]. Extracellular vesicles also provide a way for the viruses to evade 
and alter immune system to prevent their own destruction [62]. The 
understanding of the precise mechanism of communication between viral 
infected cells and their microenvironment paves new directions for viral 
oncology.   
The impact of neuroendocrine modulation on HPV in cervical cancer cells 
and the biological consequences are the focus of this thesis. The possibility 
that cervical cancer derived exosomes could carry HPV oncogenes prompted 
us to specifically consider their role in manipulating the microenvironment to 
help promote cervical cancer progression.   
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Hypotheses and Specific Aims 
 
The overall hypotheses of this project are: 
1) Daily restraint stress promotes tumor growth in an orthotopic model of 
cervical cancer  
2) Adrenergic activation will result in increased levels of HPV oncogenes E6 
and E7 in cervical cancer cells  
3) Secreted HPV can be transferred via exosomes to other stromal populations 
in the microenvironment which facilitates the invasion of cervical cancer cells  
 
These hypotheses can be unified into a central hypothesis, which is modeled 
in Figure 3. HPV positive cervical cancer cells respond to catecholamines by 
increasing the oncogene’s mRNA and protein levels. The three biological 
consequences of the sustained adrenergic signaling include 1) increased 
invasion and migration of cancer cells, 2) resistance to anoikis (in both cases 
an E6/E7- dependent mechanism is suspected), and 3) the virus is packaged 
and secreted via exosomes. Following the transfer of HPV to stromal 
populations, the fibroblast cells are altered for establishing more permissive 
conditions for tumor growth and metastasis. The following specific aims will 
test the hypotheses highlighted in this project: 
Specific Aim 1: To determine the biological effect of chronic stress on cervical 
cancer growth and progression using orthotopic mouse models. 
Specific Aim 2: To determine the functional consequences of catecholamine-
mediated increases in HPV oncogenes E6 and E7 in cervical cancer cells. 
11	  	  
Specific Aim 3: To evaluate the role of exosomal HPV oncogenes in cell-to-
cell communication in the tumor microenvironment.  
 
Figure 3. Central Hypothesis. HPV positive cervical cancer cells respond to 
stress hormones by increasing HPV oncogene expression. Biological 
consequences of stress in cervical cancer cells include increased invasion 
and migration and resistance to anoikis. The cervical cancer cells can secrete 
HPV in exosomes, which modulate the tumor microenvironment by being 
uptake by cell types such as, fibroblast. Increases in pro-inflammatory genes 
expression and increased proliferation and migration of fibroblasts promote a 
permissive environment for tumor progression of cervical cancer.    
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Methods 
 
Cell lines and tissue culture  
 SiHa and CaSki cells were maintained in RPMI supplemented with 15% 
fetal bovine serum, and 0.1% gentamicin sulfate (Gemini Bioproducts, 
Calabasas, CA). ME-180 was maintained in McCoy's 5a Medium Modified with 
10% fetal bovine serum, and 0.1% gentamicin sulfate. C4-1 cell line was 
maintained in Waymouth's MB 752/1 medium with 10% fetal bovine serum, and 
0.1% gentamicin sulfate. The C33A cell line was cultured in Eagle's Minimum 
Essential Medium supplemented with 10% fetal bovine serum, and 0.1% 
gentamicin sulfate. The telomerase-immortalized human normal ovarian 
fibroblast (NOF) line NOF151-hTERTwere maintained in  MCDB 105/199 
medium (1:1) supplemented with 10% fetal bovine serum, 0.01% epidermal 
growth factor, and 0.01% Penicillin Streptomycin. All experiments were 
performed at 70-85% confluence and cell lines were routinely screened for 
mycoplasma.  
Table 1. Cervical cancer cell lines and HPV status 
Cervical cancer cell line  HPV status 
SiHa Positive, HPV 16 
CaSki Positive, HPV 16 
ME-180 Positive, HPV 18 
C4-1 Positive, HPV 18 
C33A Negative 
 
Animal studies 
 All animal work was done in accordance with protocols approved by the 
MD Anderson Institutional Animal Care and Use Committee.  Experiments 
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involving human cells lines were performed in 8-12 weeks-old female athymic 
nude obtained from Taconic Farms (Hudson, NY). All animals were cared for in 
the accordance to the guidelines set forth by the American Association for 
Accreditation of Laboratory Animal Care and the US Public Health Service policy 
on Human Care and Use.  
 
In vivo model of cervical cancer and tissue processing  
 For all animal experiments, cells were harvested using trypsin-EDTA, 
neutralized with FBS-containing media, washed, and re-suspended to the 
appropriate cell number in HBSS prior to injection. SiHa and ME-180 cells 
(1x106) cells were transduced with lentivirus-encoding luciferase and expanded 
for injection. Nude mice were anesthetized using a ketamine-­‐‑based  anesthesia  
(100  mg/kg ketamine,   2.5  mg/kg  xylazine,   2.5  mg/kg  acepromazine) prior to 
surgery. After complete anesthesia, a small incision was made in the lower 
abdomen and the uterus was exposed where we then injected cells onto the top 
of the cervix where it meets the lower uterine segment. Mice were anesthetized 
with isoflourane and imaged once weekly for luminescent signals using Xenogen 
IVIS system. Tissue specimens used for all analyses were fixed in either optimal 
cutting temperature compound (OCT) (Miles, Elkhart, IN), formalin, or snap 
frozen in liquid nitrogen. Blood was collected immediately before necropsy, 
serum was allowed to clot for 20 minutes at room temperature. Samples were 
then centrifuged for 30 minutes at 2500 RPM. Supernatant was collected and 
stored at -80°C.  
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Restraint Stress Model 
To experimentally induce stress, we use a daily restraint-stress procedure 
in which the animals are enclosed in a movement-restricted space for 2 hours 
daily for 21 days. Animals were given 7 days after laparotomy surgery to recover 
before restraint stress started. The nude mice were randomized (10 mice per 
treatment) into four groups: 1) control no stress, 2) control restraint stress, 3) 
propranolol no stress, and 4) propranolol restraint stress. All mice received daily 
intraperitoneal injection of PBS or propranolol, 2mg/kg. Animals were 
subsequently sacrificed seven days after stress was ceased. Researchers 
blinded to the groups noted distribution, mouse weight, tumor weight, and the 
number of nodules. The same model system was used for the E6/E7 siRNA 
experiment.  
 
SiRNA preparation and treatment  
 HPV16 E6/E7 (GUCGAUGUAUGUCUUGUUGCAGAUC) and non-
targeting control (UUCUCCGAACGUGUCACGU) sequence specific siRNA was 
obtained from Sigma Aldrich (Woodlands, TX). For in vitro studies, Lipofectamine 
2000 transfection reagent (Invitrogen, Carlsbad, CA) was used according to 
manufacturer protocol to transiently transfect cells. For in vivo studies, siRNA 
was incorporated into 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC) 
nanoliposomes. For each treatment, 3.5 µg of siRNA was reconstituted in 200µl 
of sterile phosphate-buffered saline (PBS) and administered by intraperitoneal 
injection biweekly.  
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Quantitative real-time PCR 
 Total RNA from either tumor tissue or cell lines was extracted using 
Qiagen RNeasy Kit (Qiagen, Valencia, CA). Free-circulating RNA from serum or 
conditioned media was isolated using QIAamp Circulating Nucleic Acid Kit 
(Qiagen, Valencia, CA). cDNA was generated using 1µg of the RNA using Verso 
cDNA kit (Thermo Scientific, Houston, TX) per the manufacturer’s instructions. 
cDNA was subjected to amplification via real-time PCR using specific primer 
sequences (100ng/µl) which are specified in Table 1. Quantitative values were 
obtained for each sample that was normalized to its 18S content.  
 
Conventional PCR 
 DNA was extracted from serum, conditioned media, or exosomes using 
QIAamp MiniElute Virus Spin Kit (Qiagen, Valencia, CA). 1 µl of extracted total 
DNA or cDNA was used as template. All PCRs were performed in a final volume 
of 25 µl under identical conditions on an Applied BioSystems 9500. PCR 
amplification was performed with 1µl of each primer (100ng/µl), 12 µl of PCR 
Master Mix (Promega, Madison, WI) and 9.5 µl dH2O. The PCR mixture was 
subjected to 30 cycles of amplification consisting of denaturation at 94°C for 1 
min, annealing at 54°C for 45 s, and elongation at 72°C for 1 min. The first cycle 
was preceded by 3 min of denaturation at 94°C and the last cycle was followed 
by 10 min incubation at 72°C. The integrity of extracted mRNA was tested by 
amplification of Beta-Actin. Amplification products were analyzed by 
electrophoresis on 2-5% agarose gels and stained with Ethidium Bromide.  
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Table 2.PCR primer sequences.  
Gene Forward Sequence Reverse Sequence 
HPV16 
E6/E7 
AAGCAACAGTTACTGCGACGTG 
 
GCCCATTAACAGGTCTTCCAAA 
 
HPV 
16 E6 
AATGTTTCAGGACCCTACGG 
 
TCAGGACACAGTGGCTTTTG 
 
HPV 
16 E7 
TTTGCAACCAGAGACAACTGA 
 
GCCCATTAACAGGTCTTCCA 
 
HPV 
16 E2 
CGGAAATCCAGTGTATGAGC GAGGCTGCTGTTATCCACAA 
HPV16 
L1 
TTATTGCTGATGCAGGTGAC 
 
AGCACGGATGAATATGTTGC 
 
HPV 
18 E7 
GCATGGACCTAAGGCAACAT 
 
TGTTGCTTACTGCTGGGATG 
 
PTGS2 CCCTTGGGTGTCAAAGGTAA GCCCTCGCTTATGATCTGTC 
VEGF AGCTGCGCTGATAGACATCC CTACCTCCACCATGCCAAGT 
IL6 GTCAGGGGTGGTTATTGCAT AGTGAGGAACAAGCCAGAGC 
IL8 AGCACTCCTTGGCAAAACTG CAAGAGCCAGGAAGAAACCA 
CXCL2 GCTTCCTCCTTCCTTCTGGT GGGAGAAAGCTTGTCTCAA 
ADRβ1 AAGGAACATCAGCAAGCCAC GTGAACTCGAAGCCCACAAT 
ADRβ2 TCCACCTGGCTAAGGTTCTG TGTCCTTCTACGTTCCCCTG 
ADRβ3 CTTCTTTCTGGCCAACGTG CAGTAGATGAGCGGGTTGAAG 
18S CGCCGCTAGAGGTGAAATTC TTGGCAAATGCTTTCGCTC 
 
Immunoblotting 
  Lysates from cultured cells or tumor were prepared for immunoblotting 
using modified RIPA buffer (50mM Tris-hcl [pH 7.4], 150 mM NaCl, 1% Triton, 
0.5% deoxycholate) plus 25 µg/ml leupeptin, 10 µg/ml aprotinin, 2mM EDTA, and 
1mM sodium orthovanadate. The concentration of protein samples was 
determined using a BCA Protein Assay Reagent kit (Pierce Biotechnology, 
Rockford, IL). Lysates were loaded and separated on 8%-15% sodium dodecyl-
sulfate-polyacrylamide gels, respective to the protein of interest size. Proteins 
were transferred to a nitrocellulose membrane by semidry electrophoresis (Bio-
Rad Laboratories, Hercules, CA) overnight, blocked with 5% Bovine Serum 
Albumin for 1 hour and then incubated at 4°C with primary antibody overnight. 
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TBST was used to wash the membrane thoroughly before incubation with 
horseradish peroxidase (HRP)-conjugated secondary IgG (1:2000, GE 
Healthcare, UK) for 1 hour. An enhanced chemiluminescence detection kit 
(Pierce) was used to visualize HRP. To confirm equal loading of samples, the 
blots were probed for an antibody specific to beta-Actin (0.1 µg/ml; Sigma). 
ImageJ densitometry analysis was used for quantification.  
 
Migration and Invasion assays 
Both assays use a 24-well insert with 8uM pore size and polycarbonate 
membrane modified Boyden chamber (Coster, Boston, MA). For migration 
assays, the membrane was coated with 0.1% gelatin and an extracellular matrix 
component mixture composed of human laminin, type IV collagen and gelatin for 
invasion. Single-cell suspension of 75-100,000 tumor cells was seeded into the 
inserts in serum free media with serum containing media in the lower chamber to 
allow migration and invasion. Cells were incubated at 37°C in 5% CO2 for 8 
hours for migration and 24 hours for invasion. The membranes were fixed and 
stained at their respective time points, and counted in 5 random fields using light 
microscopy at 200x for quantification.  
 
ELISA 
Cell lysates were prepared as previously described in methods for 
immunoblotting. For both HPV16 E7 ELISA kit (MyBioSource, San Diego, CA) 
and cAMP assay kit (Cell Signaling, Danvers, MA), protein was used at the 
18	  	  
concentration of 100µg and compared to standards provided in the kits. In 
addition, conditioned media was collected from cells then centrifuged at 4°C, 
1200 RPM for 10 min. 100 µl of serum (methods for serum collection described in 
methods for tissue processing) or conditioned media were used for measurement 
of E7.  
 
Cell Viability Assay 
 Cells were plated (1x 104 in 100µl) in a 96-well plate. 24-72 hours later, 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide or MTT, was added to 
each well. Plate was incubated for 2 hours and then absorbance was read at 570 
nm (Ceres UV 900C; Bio-Tek Instrument Inc, Winooski, VT).   
 
Anoikis assay 
 Cells (5 x105 per well) were cultured on low attachment tissue culture 
plates for 24-96 hours at 37°C in 5%CO2. After incubation, the cells in 
suspension were harvested and centrifuged at 1200 RPM for 5 min. Pellets were 
washed with cold PBS supplemented with 0.01% FBS twice. 5nM of SYTOX Red 
dead cell stain (Life Technologies, Grand Island, NY) was added to the cells in 
PBS/FBS solution, this suspension was then immediately analyzed by flow 
cytometry for viability (Gallios Cell Analyzer). 
 
 
 
19	  	  
Proliferation assay 
 Cells were plated and treated with either siRNA or cultured in conditioned 
media for the duration of the experiment.  At the respective time point, cells were 
incubated with EdU (5-ethynyl-2´-deoxyuridine) at a dilution of 1:100 for 2 hours 
before analysis by flow cytometry (Gallios Cell Analyzer). Using the Click-iT EdU 
Flow Cytometry Cell Proliferation Assay Kit (Life Technologies, Grand Island, 
NY), the EdU incorporation was determined.  
 
Exosome isolation 
Cells were treated and maintained in their normal media throughout all 
experiments, 24 hours prior to exosomal isolation their media was switched to 
media supplemented with Exosome-depleted FBS (System Biosciences, 
Mountain View, CA). Cultured media was collected and centrifuged at 4°C, 2000 
x g for 30 minutes. The supernatant was removed carefully from pellet and debris 
at the bottom of the tube. Total Exosome Isolation Reagent (from cell culture 
media) (Invitrogen, Carlsbad, CA) was added 1:2; this suspension was placed on 
a rocker at 4°C overnight. Following incubation, samples were centrifuged at 
10,000 x g for 1 hour at 4°C. The exosomes, in the pellet, were suspended in 
1xPBS or Exosome Resuspension Buffer (Invitrogen, Carlsbad, CA) and used 
immediately or stored for further downstream analysis.  
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Labeling of exosomes 
 Exosomes were isolated as described in methods for Exosome isolation 
and resuspended in 100µl of PBS. 1µl of Bodipy-TR ceramide (Invitrogen, 
Carlsbad, CA) was added to exosome sample for 20 min at 37°C, protected from 
light. Excess unincorporated dye was removed following the standard protocol for 
the Exosome Spin Columns (Invitrogen, Carlsbad, CA). In short, column is 
rehydrated with PBS and exosome sample is applied directly to the center of the 
top of the column. After centrifugation, the elution in the bottom will contain just 
the labeled exosomes. Exosome tracing experiments were carried out 
immediately, excitation efficiency was analyzed for this dye at 594nm 
(LSRFortessa X-20 Cell Analyzer).  
 
HPV E7 detection by flow cytometry 
 Cells were suspended in fixative solution (eBioscience, San Diego, CA) for 
1h, RT, in the dark. 1x permeabilization washing buffer (eBioscience, San Diego, 
CA) was used to wash cells two times. Cells were stained with primary antibody 
(HPV16 E7 and HPV18 E7 1:200, Santa Cruz Biotechnology, Dallas, TX) in 100 
µl permeabilization buffer for 30 min on ice. Cells were washed once with 
permeabilization buffer before secondary (Alexa-488 conjugated anti-goat for 
HPV16 E7 or anti-mouse for HPV18 E7, 1:800) was added.  After 30 min in 
secondary on ice, suspension was washed once with FACS buffer (2% FBS in 
PBS). Flow analysis (LSRFortessa X-20 Cell Analyzer) was performed in 250µl 
of FACS buffer. 
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Conditioned media experiments 
 To prepare cultured media, cells (cancer cells, NOF, or conditioned-
fibroblast) were incubated with minimal amount necessary, in their respective 
media supplemented with exosome-free FBS, for 24 hours at 37°. Conditioned 
media for NE-treated cells was collected in the same way, treatment with NE was 
10µM at the beginning of the 24 our incubation period.  Media was removed and 
centrifuged at 1200 RPM, 4°C, for 10 min to remove debris. Media was aliquoted 
to be stored at -20°C until use or directly placed onto the specific cell type to be 
conditioned. When placed in culture to condition, cells were incubated for 2.5 
days before media was removed and replaced with a fresh aliquot of conditioned 
media or further analysis was performed at this point.  
 
Statistical analysis 
Microsoft Excel or GraphPad Prism (Microsoft, Redmond, WA) was used 
to analyze data. Continuous variables were compared using the Student t test or 
analysis of variance, and the Mann-Whitney test was used to compare 
differences. Using 2-way analysis of variance, we determined that a sample size 
of 10 animals per group would provide an effective size of 1.3 with 80% power at 
a significance level of P = 0.05. We considered P < 0.05 to be statistically 
significant. All statistical analyses were expressed as mean ± standard error of 
the mean. Kaplan-Meier analysis was used for survival analysis.   
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Results 
ADRβ expression correlates with cervical cancer patient outcome 
In light of previous studies showing the significance of adrenergic 
signaling in cancer progression, we chose to assess if ADRβ expression was 
correlated with patient survival. Among 166 tumor samples evaluated, 85% had 
high ADRβ1 and 61% had high ADRβ2 expression. Patients with high ADRβ2 
expression had decreased overall survival (p=0.38, Figure 4).  
 
Biological effect of chronic stress on cervical cancer growth and progression 
using orthotopic mouse models 
To evaluate the role of stress in cervical cancer progression, we first 
established an orthotopic model of cervical cancer since there was no model 
where cells are directly injected into the cervix. First, we injected the cell lines 
SiHa, CaSki, ME-180, and C4-1 to evaluate their tumorigenicity (Figure 5).  The 
route of injection we used was laparotomy in which cells are directly injected onto 
the cervix at the cervical-uterine junction. We observed tumors in SiHa, ME180, 
and C4-1 models. The cervical cancer tumor from an animal injected with SiHa 
cells was removed and recycled to create a cell line with high tumorigenicity and 
these were used in future in vivo experiments. Tumor growth was monitored 
weekly by IVIS imaging for the duration of the experiment. Bioluminescence 
imaging showed tumor localization at the cervix within the pelvic region (Figure 
5). Further examination of tumor showed lympho-vascular invasion and spread 
into the parametrium and pelvic wall (Figure 5). 
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Figure 4. ADRβ expression and overall survival in cervical cancer patient 
tumors. ADRβ1 and ADRβ2 expression in cervical cancer tumor samples. 
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Figure 5. Establishment of an orthotopic model of cervical cancer.  
Summary of cervical cancer cells tumorigenicity. Representative images of tumor 
growth over 5 weeks monitored by IVIS imaging, and established tumor in the 
animals at necropsy. 
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This model closely resembles the disease in the clinic and was adapted by our 
lab for further studies of studying cervical cancer progression.  
To study the biological consequence of chronic stress on cervical cancer 
progression, we used a well-characterized restraint stress model and a non-
specific β-blocker, propranolol. Animals submitted to daily restraint stress, had 
increased tumor weight and number of nodules while propranolol completely 
abrogated this effect (p<0.01 and p<0.05, Figure 6). 
We investigated whether the HPV oncogene protein levels could be 
modulated by chronic stress in our orthotopic model of cervical cancer. 
Interestingly, we observed a trend for elevated E7 protein in tumors from mice 
exposed to daily restraint stress compared to controls (Figure 7a). Serum from 
tumor bearing mice was also evaluated for E7 protein, showing elevated E7 
protein in restraint stress animals (124 vs. 177 ng/µl, Figure 7b). Further 
examination of the relative HPV E6/E7 DNA levels in the serum showed elevated 
levels in restraint stress animals (Figure 8). To dissect the effect of HPV E6 and 
E7 in our in vivo models, we silenced their expression by using DOPC 
nanoparticles. Daily restraint stress lead to increased tumor growth and nodules, 
while use of HPV16 E6/E7 DOPC siRNA nanoparticles completely blocked this 
effect (p<0.0001 and p<0.001, Figure 9). In addition, HPV16 E6/E7 siRNA-DOPC 
blocked restraint stress-induced increases in E7 protein in serum, shown by 
ELISA (p<0.0001, Figure 10). 
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Figure 6. Effect of restraint stress on cervical cancer growth. Total tumor 
weight and number of nodules are shown in the SiHa cervical cancer restraint 
stress model following treatment with propranolol. **indicates p<0.01, *indicates 
p<0.05. (n= 10 animals per group) 
 
 
 
 
 
27	  	  
 
Figure 7.  E7 protein expression in tumor and serum samples from restraint 
stress in vivo. E7 protein was measured by ELISA. Graphs represent E7 protein 
per 100µg of protein lysate (A), or 100µl of serum (B). (n= 3 animals per group) 
 
Figure 8. HPV16 E6/E7 DNA expression in serum from cervical cancer-
bearing mice. DNA was isolated from 25µl of serum, relative E6/E7 DNA 
expression is shown above. (n= 3 animals per group) 
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Figure 9. Effect of HPV16 E6/E7 siRNA in restraint stress model of cervical 
cancer. Total tumor weight and number of nodules are shown in SiHa cervical 
cancer model following treatment with E6/E7 siRNA-DOPC. ****indicates 
p<0.0001, ***indicates p<0.001. (n= 10 animals per group) 
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Figure 10.  E7 protein expression in serum samples from cervical cancer 
restraint stress in vivo with HPV16 E6/E7 siRNA. E7 protein was measure by 
ELISA. Graph represents E7 protein per 40µl of serum. ****indicates p<0.0001. 
(n= 5 animals per group) 
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The functional consequences of catecholamine-mediated increases in HPV 
oncogenes E6 and E7 in cervical cancer cells 
To determine the mechanism and cellular consequences of stress 
hormones in cervical cancer cells we first looked at ADRβ expression in a panel 
of cell lines by RT-PCR. CaSki, SiHa, ME-180, and C4-1 show expression of β1, 
β2, and β3 receptors (Figure 11a). C33A cervical cancer cells are null for all 
three of these receptors; therefore we introduced a β2 construct for future 
experiments requiring an HPV negative cell line to study the effect of stress 
hormones (Figure 11b).  To determine if these cells could respond to adrenergic 
activation, we measured cAMP levels after exposure to NE or a non-specific β-
receptor agonist, isoproterenol (ISO), for 30 min. A significant increase in cAMP 
levels was observed in NE and ISO treated ADRβ-positive cells CaSki and SiHa 
(p<0.05, Figure 12).  
Our in vivo model shows HPV E6 and E7 protein levels were elevated in 
daily restraint stress animals tumor and serum, therefore we sought to 
investigate the underlying mechanism driving this increase. We first examined if 
catecholamines increased E6/E7 mRNA expression in CaSki, SiHa, and ME-180 
cells. The quantitative PCR data shows NE or ISO exposure leads to increases 
in E6/E7 mRNA by three fold in CaSki (p<0.001, Figure 13). SiHa and ME-180 
show similar increases in mRNA at 12 hours post-treatment with catecholamines 
(p<0.001 and p<0.01, Figure 13).  
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Figure 11. ADRβ expression in a panel of cervical cancer cell lines. ADRβ1, 
ADRβ2, and ADRβ3 expression were analyzed by qRT-PCR in CaSki, SiHa, ME-
180, and C4-1 (A), C33A and C33A-B2 construct (B). Skov3 is an ovarian cancer 
cell line, used here as a positive control.  
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Figure 12. Intracellular cAMP levels after adrenergic stimulation. Cervical 
cancer cells were exposed to NE or ISO and intracellular cAMP levels were 
measure by ELISA. *indicates p<0.05. 
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Figure 13. Relative HPV oncogene mRNA expression after catecholamine 
exposure. Following treatment with NE or ISO, cervical cancer cells relative 
mRNA expression for HPV16 E6/E7 (CaSki and SiHa), and HPV18 E7 (ME-180) 
were analyzed by qRT-PCR.****indicates p<0.0001, ***indicates p<0.001, 
**indicates p<0.01, *indicates p<0.05. 
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Since HPV was detected in the serum from tumor-bearing mice, we 
analyzed the corresponding supernatant from these treated cells for E7 protein 
by ELISA. There was an increase in E7 after 6 hours with NE or ISO (Figure 14). 
Next, we analyzed viral DNA isolated from the supernatant samples. qRT-PCR 
analyses show 9-fold increases in E6/E7 DNA in the supernatant from samples 3 
hours post-treatment with NE and ISO (Figure 15). This data provides evidence 
that catecholamines can increase the production and secretion of HPV E6 and 
E7.  
 To examine the cellular response and consequences of stress hormones 
in cervical cancer cells we first investigated invasion and migration of cervical 
cancer cells treated with NE compared to control. SiHa and ME-180 cervical 
cancer cells were treated with NE, and allowed to invade or migrate through a 
defined matrix or gelatin coated membrane for 6 hours or 24 hours, respectively. 
NE increased cervical cancer invasion (SiHa 127 vs. 156 cells per HPF, p=0.01 
and ME-180 97 vs. 138 cells per HPF, p=0.03, Figure 16a, b) and migration 
(SiHa 25 vs.42 cells per HPF, p=0.03, Figure 17). To investigate if HPV E6/E7 
aids cervical cancer invasion, we treated cells with E6/E7 siRNA prior to the 
assay. Transfection with siRNA did not lead to changes in cell proliferation or 
viability (data not shown). Cells treated with siRNA showed reduction in invasion 
when compared to control (p<0.0001, Figure 18). Further, while NE increased 
tumor cell invasion, E6/E7 siRNA completely abrogated this effect (p<0.05 and 
p<0.0001, respectively, in Figure 18). 
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Figure 14. HPV16 E7 protein expression in supernatant from SiHa cells 
exposed to catecholamines. Following treatment with NE or ISO cervical 
cancer cells E7 protein expression was measured by ELISA in supernatant. 
**indicates p<0.01. 
  
36	  	  
 
Figure 15. HPV16 E6/E7 DNA expression in supernatant from SiHa cells 
exposed to catecholamines. DNA was isolated from supernatant, relative 
E6/E7 DNA expression is shown above. ****indicates p<0.0001, 
**indicates<0.01, *indicates p<0.05. 
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Figure 16. Invasion of cervical cancer cells treated with NE. Cervical cancer 
cells were treated with NE and then plated into modified Boyden chambers to 
assess invasion (24 hours). Cell numbers per high power field (HPF, 200X) were 
then counted. *indicates p<0.05. 
  
A) 
B) 
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Figure 17. Migration of cervical cancer cells treated with NE. Cervical cancer 
cells were treated with NE and then plated into modified Boyden chambers to 
assess migration (6 hours). Cell numbers per high power field (HPF, 200X) were 
then counted. *indicates p<0.05. 
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Figure 18. Invasion of cervical cancer cells with E6/E7 siRNA. Cervical 
cancer cells were treated with HPV16 E6/E7 siRNA 36 hours prior to treatment 
with NE and plated into modified Boyden chambers to assess invasion (24 
hours). Cell numbers per high power field (HPF, 200X) were then counted. 
****indicates p<0.0001, *indicates p<0.05. 
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To further elucidate the mechanism by which the stress-induced increases 
in HPV oncogenes can promote cervical cancer growth and metastasis we 
examined their role in anoikis. Anoikis is a process by which cells enter apoptosis 
when detached from the extracellular matrix and neighboring cells. We assessed 
ME-180 cancer cells maintained in low attachment tissue culture plates for basal 
anoikis rates every 24 hours; cells were analyzed by flow cytometry for SYTOX 
Red dead cell stain to determine viability. After 48 hours in these conditions, 50% 
of the cells went through anoikis and at 72 hours 75% went through anoikis 
(Figure 19). Exposure to NE resulted in significant inhibition of anoikis in ME-180 
cells (p<0.0001, Figure 20). 
 
The role of exosomal HPV oncogenes in cell-to-cell communication in the tumor 
microenvironment 
We sought to investigate the biological significance of secreted HPV. 
Specifically, we wanted to know if cancer cells and the extracellular HPV can 
condition their microenvironment into one that is more supportive for tumor 
growth. In this case, we looked at fibroblasts because they have been shown to 
be modulated directly by cancer cells [50].  Normal fibroblast cell lines 151 (NOF) 
were exposed to supernatant from C33A or SiHa for two days. In the study done 
by, Hanahan et. al, genes such as CXCL2, VEGF, IL-6 and IL-8 were said to be 
part of the pro-inflammatory gene signature observed in cancer-associated 
fibroblast [63]. In our experiment, NOF showed an up-regulated cancer 
associated pro-inflammatory gene signature within two days of culture with SiHa  
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Figure 19. Basal anoikis rates of ME-180 over 72 hours. Percent of cells 
stained as positive for SYTOX Red are graphed here as percent anoikis over 
72h.  
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Figure 20. NE-induced resistance to anoikis. Cells treated daily with NE are 
represented here, compared to control. Percent of cells stained positive for 
SYTOX Red are graphed here as percent anoikis. ****indicates p<0.0001.  
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(HPV+) conditioned media when compared to C33A (HPV-) conditioned media 
(Figure 21a). Furthermore this effect was amplified when fibroblast were exposed 
to media from cells treated with NE (Figure 21b). Since we previously showed 
HPV in the supernatant, we wanted to see if the NOF became HPV positive after 
incubation with the cultured media from SiHa cells. Fibroblasts that were cultured 
with conditioned media from SiHa for two days had detectable HPV E6/E7 mRNA 
after just 24 hours (p< 0.0001, Figure 22). Proliferation of fibroblast has been 
shown to increase when co-cultured with breast cancer cells [64].  To assess if 
there was a functional consequence of the CAF conversion by cervical cancer 
cells, we analyzed proliferation of the fibroblast conditioned with SiHa cultured 
media, with or without NE. There was an increase in fibroblast proliferation, seen 
by percent of EdU incorporation after 2 days of co-culture (Figure 23). Since this 
was not a robust biological effect, we looked into other functional read outs, 
which could be the main driver in how NOF to CAF conversion can promote 
progression of cervical cancer. 
A change in migration of fibroblasts is a signature characteristic of 
transition from normal to a cancer-associated phenotype. To assay the ability of 
fibroblast to migrate following exposure to conditioned media, fibroblasts were 
cultured for five days and then were plated into gelatin coated modified Boyden 
chambers for 8 hours. As expected, NOF fibroblasts cultured with conditioned 
media from SiHa cervical cancer cells had increased migration, this effect was 
amplified with conditioned media from cervical cancer cells treated with NE (24 
vs. 93 and 24 vs. 164, p<0.01 and p<0.001, Figure 24).  
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Figure 21. Pro-inflammatory genes expression in fibroblast conditioned 
with cervical cancer cell supernatant. mRNA expression changes were 
analyzed by qRT-PCR in fibroblast cultured with SiHa and C33A conditioned 
media over 2 days. *indicates p<0.05. 
A) 
B) 
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Figure 22. HPV mRNA expression in fibroblast conditioned with SiHa cell 
supernatant. Analysis of HPV16 E6/E7 mRNA expression by qRT-PCR in 
fibroblast after culture with supernatant from SiHa cells.****indicates p<0.0001. 
*indicates p<0.05. 
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Figure 23. Effect of SiHa cell conditioned media on fibroblast proliferation. 
Proliferation graphed as percent of EdU incorporation in fibroblast over 2 hours, 
48 hours after placed in SiHa cultured media.**indicates p<0.01.*indicates 
p<0.05  
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Figure 24. Migration assay for fibroblast with conditioned media from SiHa 
cervical cancer cells. Fibroblasts were plated into modified Boyden chambers 
to assess migration (8 hours) to conditioned media from cervical cancer cells. 
Cell numbers per high power field (HPF, 200X) were then counted. ***indicates 
p<0.001. **indicates p<0.01. 
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It has been suggested that HPV can only infect stratified epithelium. 
Based on our previous finding that HPV E6/E7 mRNA was detectable in NOF 
cultured with supernatant from SiHa cells, we wanted to determine how the virus 
can infect other cell types. Therefore we hypothesize that HPV viruses can be 
packaged into exosomes and transferred to nearby fibroblasts. First, we isolated 
exosomes from cervical cancer cells and validated the extraction by determining 
the presence of hsc70 on these samples (Figure 25).  
The interaction of the cancer cells and the stromal populations, as well as 
the ability to penetrate and breakdown the basement membrane represent critical 
steps in the metastatic process [65]. To see if the exosomes themselves were 
capable of invading a defined matrix that mimics the basement membrane, 
exosomes labeled with a red fluorescent dye, Bodipy-TR ceramide, were placed 
in an insert coated with defined matrix and allowed to invade for 24 hours. 
Fluorescence imaging shows that exosomes were able to penetrate through the 
matrix and further they can be visualized amongst cancer cells that were plated 
below the insert (Figure 26).  
To delineate a mechanism by which normal fibroblasts acquire viral 
oncogene expression, we specifically looked at the ability of normal fibroblast to 
uptake cervical cancer derived exosomes. Fibroblasts were incubated with 
Bodipy-TR ceramide labeled exosomes for 24 hours and analyzed by flow 
cytometry. These analyses demonstrate that fibroblast can uptake labeled 
exosomes (Figure 27).  
 
49	  	  
 
 
Figure 25. Hsc70 expression by western blot in exosomes isolated from 
cervical cancer cells. Exosomes were isolated from cervical cancer cells and 
expression was confirmed by western blot. 
 
  
50	  	  
 
 
 
Figure 26. Invasion of cervical cancer cell derived exosomes. Labeled 
exosomes were plated into modified Boyden chambers to assess invasion (24 
hours). Ability to penetrate the matrix was determined by Bodipy-TR ceramide 
signal seen in cancer cells plated below the inserts. 
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Figure 27. Uptake of cervical cancer cell exosomes by fibroblasts. Flow 
cytometry results are shown above, the mCherryA positive population represents 
the fibroblasts that have taken up Bodipy-TR ceramide labeled cervical cancer 
exosomes.  
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Since endocytosis is energy dependent process, cells put at 4°C show the 
uptake of exosomes is compromised and it completely abrogated this process.  
Moreover, to determine if exosomes were a key carrier of HPV viruses, we 
incubated fibroblasts with Bodipy-TR ceramide labeled exosomes from SiHa and 
ME-180 cervical cancer cells for 24 hours. We detected Alexa-488 conjugated 
HPV E7 and the Bodipy-TR ceramide label in fibroblast by flow cytometry. Our 
data showed that fibroblasts can uptake exosomes containing HPV E7 proteins 
(Figure 28).  
NOF treated with cervical cancer supernatant showed enhanced migration 
and an increase in some pro-inflammatory genes, which are both supportive of 
these cells differentiating into CAFs. SiHa cells conditioned with these converted 
fibroblast cultured media resulted in significantly increased invasion when 
compared to cells treated with conditioned media from NOF (60 vs. 111, 
p<0.0001, Figure 29).  
To study if intervention with siRNA for specific genes involved in 
exosomes release pathways will abrogate the effects we have seen, we first 
silenced the gene SMPD2 in cervical cancer cells. Three sequences were used 
to validate knock down of the SMPD2 mRNA in SiHa cells (Figure. 30).  All three 
of the sequences show a 90% knockdown of SMPD2 mRNA. Future analysis of 
supernatant from SMPD2 siRNA treated cells for E7 protein compared to control 
is necessary. This data can provide evidence that HPV uses exosomal pathways 
for oncoprotein release.  
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Figure 28. Detection of exosomal HPV E7 protein in fibroblasts. Flow 
cytometry results are shown here. The double positive population in the Q2 
quadrant represents the fibroblasts that have taken up the Bodipy-TR ceramide 
positive exosomes and E7 protein (HPV E7 specific antibodies were conjugated 
to Alexa 488 fluorescent secondary antibody for detection by flow). 
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Figure 29. Invasion of cancer cells co-cultured with HPV-CAFs. Normal 
fibroblasts were cultured with SiHa conditioned media. HPV positive fibroblasts 
were co-cultured with SiHa cells for 24 hours prior to plating them into modified 
Boyden chambers for invasion assay (24 hours). Cell numbers per high power 
field (HPF, 200X) were then counted. ****indicates p<0.0001. 
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Figure 30. SMPD2 siRNA in cervical cancer cells. Three sequences were 
used to validate siRNA efficiency specific for the SMPD2 gene in cervical cancer 
cells.  
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Discussion 
Biological significance of stress in cervical cancer progression  
While chronic stress has been previously implicated in the progression of 
many cancers, the biological significance in cervical cancer had not been 
explored. In our detailed investigation of how chronic stress contributes to 
cervical cancer progression, we first show daily restraint stress led to increases 
in tumor weight and number of nodules in an orthotopic murine model of cervical 
cancer. The use of a non-specific beta-blocker, propranolol, completely 
abrogated this effect. This finding is suggestive that there is a link between 
sustained adrenergic signaling and cervical cancer progression. We provide 
evidence that HPV oncogene transcription and translation increases after 
catecholamine exposure. This is the first time HPV has directly been shown to 
respond to adrenergic signaling. The relationship between catecholamines and 
increased HPV is important, as HPV is the primary cause of cervical cancer and 
is capable of manipulating numerous pathways in cancer cells [66]. The 
significance of HPV oncogenes in a chronic stress model is most dramatically 
illustrated by the complete abrogation of tumor growth and number of tumor 
nodules when E6/E7 siRNA was used.  
In the current study, HPV protein was elevated in tumors and serum from 
restraint stress animals when compared to control. This data shows 
catecholamines can increase the secretion of HPV in addition to enhancing its 
transcriptional activity in cancer cells. Although HPV has been detected outside 
of the cell [67], the mechanism by which the virus is maintained extracellularly is 
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not understood. We demonstrate, for the first time, cervical cancer derived 
exosomes contain HPV oncoproteins. Perhaps the mechanism the virus uses to 
maintain latent and persistent infection in an individual is through packaging itself 
in cancer cell derived exosomes. Further we show that the HPV containing 
exosomes directly interact with fibroblasts, suggesting a novel mechanism HPV 
uses for infecting non-epithelial cell populations in the tumor microenvironment. 
Our study provides new directions for defining precise mechanisms by which 
HPV plays a role in cervical cancer tumor progression. 
 
Mechanisms 
To our knowledge, this is the first time neuroendocrine modulation of HPV 
via SNS has been demonstrated. In this study, we prove NE-induced increases 
in E6/E7 are required for cervical cancer cell invasion. Additionally, cervical 
cancer cells expressing E6/E7 show an increased resistance to anoikis when 
treated with NE. Together these results demonstrate the consequences of 
catecholamine-mediated increases in HPV oncogenes.  
The unique and heterogeneous expression of β-receptors in these cervical 
cancer cell lines makes delineating one overarching mechanism and pathway 
driving increases in HPV oncogenes intricate. To study this mechanism, siRNA 
targeting specific ADRβs will be most definitive in identifying the signaling 
pathway driving these increases. More evidence is needed to support both 
ADRβ-dependent and HPV-dependent processes and their interplay. We did not 
address this issue specifically, however a model with HPV negative cells that 
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have a functional response to adrenergic stimulus could address the 
catecholamine-dependent effects of chronic stress on tumor progression. When 
stable expression of HPV is added into this specific model and compared, we 
hypothesize the stress effect will be amplified.  
While many studies have focused on the effect of HPV in tumor cells and 
how the virus function plays a role in oncogenesis [68], we provide a role of the 
virus in conditioning the microenvironment and how it may support progression of 
cervical cancer. The exosomes from cervical cancer cells were shown to contain 
the oncogene E7, supporting a route by which cancer cells are directly 
modulating their environment via oncogene transfer. After determining the ability 
of exosomes to penetrate a basement membrane like setting, we wanted to 
examine the capability of these exosomes to be uptake by cells found in the 
microenvironment such as; immune cells, macrophages, endothelial cells, or 
fibroblast.  The data presented here shows fibroblasts can uptake cervical cancer 
cell derived-exosomes.  Another avenue we can explore to determine the 
significance of the exosomes is their role in vivo in tumor progression by using 
CD63-GFP labeled cancer cells. Analysis of these tumors and the surrounding 
tissue can help us understand the extent to which the exosomes are released in 
vivo and where they are primarily taken up or located. Furthermore, we can 
explore the effect of the exosomes on the other cell types in the 
microenvironment that we did not elucidate on here.  
Several other experiments are necessary to dissect specifically what the 
exosomes alone are contributing to the fibroblast. Experiments addressing the 
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cervical cancer cell derived exosomes are critical so we can know more about 
their content, release, and uptake. The exosomal release mechanisms are of 
primary interest because interfering with these pathways can abolish the 
communication and delivery of these oncogenes from the tumor in the first place.  
To block exosomal release, inhibitors or siRNA for Rab family members (Rab11, 
Rab27, Rab35), SMPD2 shRNA, or inhibitors of the endosomal sorting 
complexes required for transport (ESCRT) machinery can be used [55]. 
Experiments using these types of inhibitors will definitively support if the 
exosomes are the component in the cervical cancer cultured media that are 
responsible for altering the fibroblast by transferring HPV oncogenes to them.  
Furthermore, the inhibitors that show most efficacies in vitro can be formulated 
for application in an in vivo setting. Studies addressing exosomal release and 
developing ways to disrupt these pathways could provide beneficial therapeutic 
targets, which could be used in adjuvant to current treatment options. 
The ability of cancer cells to modulate fibroblast, and become CAFs, has 
been recently established for breast, ovarian, and prostate cancers [64].   We are 
currently showing the fibroblast conditioned by cervical cancer cells have 
increased migration, proliferation, and increased pro-inflammatory gene 
expression. Furthermore we support a paracrine feedback on the cancer cells 
from the reprogrammed fibroblasts, which caused an increase in cancer cell 
invasion. It is possible that exosomes released from the conditioned vs. normal 
fibroblast are different in content and concentration which can directly be 
affecting the cancer cells. The communication between the cancer cells and 
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fibroblasts is demonstrated here as a potential explanation for priming the tumor 
microenvironment. The mechanism underlying the communication from the CAFs 
to cervical cancer cells which leads to increased invasion needs to be dissected. 
This study provides a mechanism by which cell-to-cell communication is 
promoting cervical cancer progression via a positive feedback loop. 
To determine if HPV is required in the CAF-like transformation of normal 
fibroblast, the role of HPV in the fibroblast needs to be examined. Based on our 
evidence, we show a novel mechanism for viral packaging and infection via 
exosomes to the fibroblasts. The specific interactions E6 and E7 proteins have in 
the fibroblast are unidentified to this point and a mass spectrometry analysis of 
this would be of interest. To address the transforming capabilities of HPV 
oncogenes in the fibroblasts, a stable expression of HPV E6/E7 in fibroblasts is 
necessary. 
  
Clinical implications 
We demonstrate a reliable animal model for studying the progression of 
cervical cancer. Our orthotopic model of cervical cancer closely resembles the 
tumor growth and spread that is seen in the clinic. This model has excellent 
efficiency and gives researchers the ability to accurately predict clinical 
outcomes.  
Our study has important clinical significance. We show the significant 
reductions in tumor burden with the use of propranolol in cervical cancer. This is 
an extremely important foundation to support using β-blockers in clinic in 
61	  	  
combination with other therapies for cervical cancer, to prolong survival and help 
make current therapies more effective. ADRβ2 expression was related to overall 
survival in cervical cancer patients, which complements why the use of beta-
blockers in this population could be beneficial.  
Detection of HPV in patients has recently been used as a diagnostic 
marker simultaneously with abnormal cervical cytology, to increase the amount of 
screening a patient is advised in the hopes of preventing lesions or detecting 
lesions in very early and treatable stages [69]. The relationship between HPV 
expression and progression of the disease in patients, such as tumor stage and 
grade or overall survival, should be further studied in patients. Also, ISH for HPV 
DNA in tumor tissues will further tell us more about the interplay between the 
microenvironment and developed tumors. We predict the patients with high-HPV 
in the blood will additionally have more invasive tumors, more metastasis, and 
poorer overall survival. This data together could be further correlated with 
depression or stress assessments to support a clinical relationship between 
psychosocial distress and cervical cancer progression. 
 Exosomes are currently of interest in the nanotech field for therapeutic 
potential. Investigation of whether or not E6/E7 silencing will minimize the 
progression through less transfer of oncogenes is pending. Further examination 
by use of high-throughput platforms such as RPPA or gene array of the cervical 
cancer cell derived exosomes will provide more insight into the biogenesis and 
content of these vesicles. This disease has a very long time until it presents with 
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large and bulky tumor and if we can prevent the virus from potentiating its effects 
in progression we eliminate a hurdle current therapies do not address.   
 
Conclusions 
Evidence presented offers a new insight into not only stress-related 
pathways but also viral oncology and overall tumor biology. We addressed the 
three hypotheses of this project. In the current study, we demonstrate a 
previously unrecognized role of sustained adrenergic signaling in cervical cancer 
tumor progression. We show chronic stress increases HPV oncogene expression 
in vivo and in vitro. Catecholamine-driven increases in HPV promote tumor 
progression through increased cancer cell invasion and resistance to anoikis in 
vitro. Further review of HPV led us to the finding that the virus is secreted and 
has an emerging role in manipulating the microenvironment. We offer a complex 
but reliable model for explaining the influence of viral transfer through exosomes 
to the microenvironment.  More importantly, the stromal changes are shown to 
play a biologically significant role in promoting cervical cancer cell invasion. 
Collectively, these data are translatable findings that need to be further examined 
and pursued to uncover the mechanisms behind our research. 
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